CVS Health Corporation: UBS cuts target price to $107 from $118
CVS•UBS cut its target price for CVS Health Corporation to $107 from $118.
Related News
Charles River Laboratories International: UBS raises target price to $387 from $357
CRL•
IMAX Corporation’s Q3 net income rises to USD 113.81 million
IMAX•
Arko Petroleum Corp: UBS cuts target price to $19 from $21
APC•
Ameriprise cuts voting rights in Cairn Homes to 2.864% from 3.535%
AMP•
Evergy expects earnings per share to grow about 9.5% annually from 2028 to 2030
EVRG•